-
Mashup Score: 2FDA Approves Avacopan to Treat ANCA-associated Vasculitis - 3 year(s) ago
The FDA has approved avacopan (Tavneos) as an adjunctive treatment for severe ANCA-associated vasculitis.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0New Vasculitis Treatment Guidelines: What Rheumatologists Should Know - Docwire News - 3 year(s) ago
The American College of Rheumatology (ACR) and the Vasculitis Foundation released three new clinical practice guidelines for treating and managing
Source: Docwire NewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
ICYMI: New #Vasculitis Treatment Guidelines: What #Rheumatologists Should Know: #PM101 https://t.co/ta0cXrdUUP via @mydocwire @ACR_Journals: https://t.co/QnhPmDeqDb #AAV #ANCA #GPA #EGPA #MPA https://t.co/lupqP3W8V6
-
-
Mashup Score: 1Clinical Practice Guidelines Vasculitis - 3 year(s) ago
Read American College of Rheumatology clinical practice guidelines for the prevention and treatment of vasculitis.
Source: www.rheumatology.orgCategories: Latest Headlines, RheumatologyTweet-
Key theme in new ACR/@VasculitisFound clinical practice guideline: Increasing use of biologics to treat systemic #vasculitis—e.g., #tocilizumab for #GCA, #rituximab for #ANCA-associated vasculitis, #mepolizumab for #EGPA → https://t.co/mvCfVlxnsF https://t.co/2TbVDkawKU
-
-
Mashup Score: 2ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification - 3 year(s) ago
Primary and secondary ANCA-negative pauci-immune necrotizing glomerulonephritis. Pauci-immune necrotizing glomerulonephritis (PING) is a small-vessel kidney vasculitis usually associated with the presence of anti-neutrophil cytoplasm antibodies (ANCA) directed against the myeloperoxidase or the proteinase 3. A minority of patients with PING do not have this type of ANCA. To describe the clinical…
Categories: Latest Headlines, NephrologyTweet-
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification https://t.co/XCyry3BYBm @RonsinCharles @LudivineLebour1 @MoglieQuintrec @karine_renaudin @AKI #ANCA #VisualAbstract https://t.co/fz0dtyi6lf
-
-
Mashup Score: 0FDA Advisors Split on New Drug for Vasculitis - 3 year(s) ago
Concerns raised about study design and off-protocol use of steroids
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
FDA Advisors Split on New Drug for #Vasculitis https://t.co/MmZQpTPgP2 #Rheumatology #rheum #ANCA #AAV #StudyDesign #PM101 #avacopan, an oral small molecule inhibitor of the [#complement] #C5a receptor
-
-
Mashup Score: 1
A molecule released by platelets — cell fragments in the blood that form clots and stop or prevent bleeding — appears to contribute to the progression of ANCA-associated vasculitis (AAV) by triggering a defense mechanism carried out by white blood cells. Researchers now have identified a key…
Source: ANCA Vasculitis NewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
Scientists Identify Molecule That Triggers #AAV-related Defense Mechanism: “#Platelet #CXCL4 mediates #neutrophil extracellular traps formation in #ANCA-associated #vasculitis” https://t.co/A0HXRN88bH
-
-
Mashup Score: 0ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study - 3 year(s) ago
Background Small studies suggest an association between ANCA-associated vasculitis (AAV) incidence and rurality, seasonality and socioeconomic deprivation. We examined the incidence of kidney biopsy-proven AAV and its relationship with these factors in the adult Scottish population. Methods Using the Scottish Renal Biopsy Registry, all adult native kidney biopsies performed between 2014 and 2018…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet-
Which factors may underlie geographic variation 🌏in #ANCA associated #vasculitis ? 🔴Seasonality ✅Rurality ▶️Important to consider socioeconomic status and health resources to reduce health disparities in #AAV 🔗https://t.co/K0HwXnhjIg https://t.co/hCqIg71ybi
-
-
Mashup Score: 0StR training series: Vasculitis - 3 year(s) ago
StR training series: Vasculitis
Source: www.rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Trainees, make sure you join our #vasculitis StR training webinar tomorrow. Topics from Dr Sarah Fordham and @cmukhtyar include #ANCA vasculitis and a #GCA update, covering management, severe manifestations and treatment strategies. Book your spot: https://t.co/IzQbxOfyLK https://t.co/NYVSfbLH2W
-
-
Mashup Score: 6Predicting relapse in ANCA-associated vasculitis: a systematic review and meta-analysis - 3 year(s) ago
AbstractObjectives. Relapses affect 30-50% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) over 5 years, necessitating lo
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
Relapse in #ANCA-associated #vasculitis Meta-analysis shows risk factors ➡️PR3 positivity ➡️Lower serum creatinine ➡️Cardiovascular involvement 👉🏽https://t.co/tb5b2PwuFE via @RheumJnl https://t.co/eZQQdbtOEb
-
-
Mashup Score: 1Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM - 3 year(s) ago
Original Article from The New England Journal of Medicine — Avacopan for the Treatment of ANCA-Associated Vasculitis
Source: New England Journal of MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Avacopan — Time to Replace #Glucocorticoids? https://t.co/Gg7DNiDdP8 https://t.co/Zrl73xOaen @NEJM https://t.co/CQzxAaCtUb "There is strong data from animal models that #C5a is directly involved in the as-yet-unidentified cause of #ANCA-associated #vasculitis" #AAV https://t.co/nozASuZzlM
-
The U.S. Food and Drug Administration approved avacopan #Tavneos for adult patients with severe active anti-neutrophil cytoplasmic autoantibody #ANCA -associated vasculitis. @US_FDA FDA US FDA News @FDAMedWatch @chemocentryxinc ChemoCentryx ChemoCentryx https://t.co/lFllsh3xvk